Immuneel Therapeutics Raises Over Rs. 100 Crore, A Big Push For India’s CAR-T Cancer Therapy Market
Immuneel Therapeutics raises over Rs. 100 crore in Series B funding to scale CAR-T therapy, manufacturing and global expansion.
Trending